Skip to main content
Fig. 5 | BMC Immunology

Fig. 5

From: Thalidomide with blockade of co-stimulatory molecules prolongs the survival of alloantigen-primed mice with cardiac allografts

Fig. 5

Serum levels of alloantibodies in skin-primed recipients on day 4 after the secondary heart transplant. a Flow cytometry analysis of Ig M (top), Ig G1 (middle), Ig G2a (bottom); b Cumulative data analysis for the proportion of b Ig M, c Ig G1 and d Ig G2a (n = 3; *, P < 0.05; **, P < 0.01; ***P < 0.001 versus skin-primed HTm ctrl)

Back to article page

BMC Immunology

ISSN: 1471-2172

Contact us